Skip to main content

Table 5 Most frequently detected regions in both blood and tissue group by array CGH

From: Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast

Cytoband

Bac_position(Start-End)

Gene

Blood frequency

Tissue frequency

copy number gain

    

1q23.1

155045002-155148010

SH2D2A, NTRK1, INSRR

11/30(37%)

14/30(47%)

3q21.1

124077821-124170592

DIRC2, SEMA5B

12/30(40%)

12/30(40%)

4p16.3

2729092-2810076

SH3BP2

15/30(50%)

10/30(33%)

5p15.33

388661-566921

AHRR, EXOC3, SLC9A3

17/30(57%)

24/30(80%)

5p15.33

557250-688780

SLC9A3, CEP72

14/30(47%)

24/30(80%)

8q24.3

145649003-145759358

CYHR1, KIFC2, FOXH1, PPP1R16A, GPT, MFSD3, RECQL4, LRRC14, LRRC24

10/30(33%)

23/30(76%)

8q24.3

145298570-145384455

 

20/30(67%)

18/30(60%)

8q24.3

145499155-145579895

HSF1, DGAT1, SCRT1, FBXL6, GPR172A, ADCK5

16/30(53%)

19/30(63%)

10q26.3

134654530-134754530

GPR123

11/30(37%)

12/30(40%)

11p15.4

2812494-2941798

KCNQ1, KCNQ1DN, CDKN1C, SLC22A18AS, SLC22A18, PHLDA2, NAP1L4

12/30(40%)

10/30(33%)

11p15.5

499204-651925

HRAS, LRRC56, C11orf35, RASSF7, IRF7, MUCDHL, SCT, DRD4, DEAF1

18/30(60%)

11/30(37%)

11p15.5

982365-1053559

AP2A2, MUC6

13/30(43%)

14/30(47%)

11p15.5-11p15.4

2759787-2881783

KCNQ1, KCNQ1DN, CDKN1C, SLC22A18AS, SLC22A18

12/30(40%)

13/30(43%)

12p13.31

6232178-6365032

PLEKHG6, TNFRSF1A, SCNN1A, LTBR

18/30(60%)

10/30(33%)

12p13.33

183679-257363

SLC6A12, SLC6A13

12/30(40%)

12/30(40%)

12q21.2

74611385-74763510

PHLDA1, NAP1L1

10/30(33%)

10/30(33%)

14q32.12

91451809-91569634

FBLN5, TRIP11, PTMAP7

13/30(43%)

11/30(37%)

15q12

24429411-24553848

GABRB3

10/30(33%)

10/30(33%)

16p13.3

979471-1055445

 

16/30(53%)

23/30(76%)

16p13.3

3369954-3513708

HS3ST4, ZNF434, ZNF174, ZNF597, CLUAP1

12/30(40%)

11/30(37%)

16q22.1

65485602-65560334

CDH16, RRAD, FAM96B, CES2

12/30(40%)

11/30(37%)

17p13.3

907028-1022423

ABR, MRPL14P1

14/30(47%)

10/30(33%)

17q11.2

24429872-24521087

MYO18A

17/30(57%)

19/30(63%)

17q21.1

35466169-35565677

THRA, NR1D1, CASC3

10/30(33%)

11/30(37%)

17q25.3

78432676-78562724

TBCD, B3GNTL1

11/30(37%)

18/30(60%)

17q25.3

77755881-77849251

SLC16A3, CSNK1D

18/30(60%)

17/30(57%)

19p13.3

5809230-5915258

FUT5, NDUFA11, CAPS, RANBP3

14/30(47%)

13/30(43%)

19q13.43

63514606-63629648

HKR2, A1BG, ZNF497, RPS5, ZNF584

11/30(37%)

10/30(33%)

20q13.33

60334240-60438865

LAMA5, RPS21, CABLES2, C20orf151

16/30(53%)

19/30(63%)

22q13.33

48930979-49068912

MOV10L1, PANX2, TUBGCP6, HDAC10, MAPK12, MAPK11, PLXNB2

15/30(50%)

15/30(50%)

copy number loss

    

6p25.3

202426-307948

DUSP22

6/30(20%)

5/30(17%)

7q22.1

100407386-100480418

MUC12, MUC17

6/30(20%)

6/30(20%)

14q32.33

105821330-105907464

IGHVIII-25-1, IGHV2-26, IGHVIII-26-1, IGHVII-26-2, IGHV7-27, IGHV4-28, IGHVII-28-1, IGHV3-29, IGHV3-30, IGHVII-30-1, IGHV3-30-2, IGHV4-31, IGHVII-31-1, IGHV3-32, IGHV3-33, IGHVII-33-1, IGHV3-33-2, IGHV4-34, IGHV7-34-1

8/30(27%)

8/30(27%)

22q11.1(Cross-Hybridized)

14461738-14573360

DUXAP8

7/30(23%)

5/30(17%)

22q11.21

17158480-17233217

GGT2

14/30(47%)

11/30(37%)

  1. Bold text indicates genes associate with many different carcinoma including breast.